Alzheimer's disease
Blood-based tests show potential for early Alzheimer’s detection
Blood-based tests show potential for early Alzheimer’s detection
More than 150 in vitro diagnostic tests are currently in development.
Neuroglee secures $10m funding to advance home-based Alzheimer's treatment
Openspace Ventures led the Series A round.
Most Read
1. Diffusion to confusion: Solving APAC’s healthcare coordination crisis 2. Singapore develops world-first fluorescent nanosensor to track gut health 3. AI adoption drives clinical decision support market to $10.15b 4. Medical inflation rises to 11.3% as employers face cost squeeze 5. AI moves from pilot phase to core pharma operationsResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Fragmented care has left patients facing inconsistent advice and complex journeys.
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential
Why health system research deserves more attention